Correct Usage of the Term “Off-Label” in the Context of Corneal Cross-Linking [Letter]

by Katz LJ
Published 2021-07-01

Treatment Success Across Different Levels of Preoperative Disease Burden: Stratified Two-Year Outcomes from the Pivotal Trial of iStent inject® Trabecular Micro-Bypass in Prima...

by Singh IP, Sarkisian Jnr S, Hornbeak D, Katz LJ, Samuelson T
Published 2021-08-01

A prospective 3-year follow-up trial of implantation of two trabecular microbypass stents in open-angle glaucoma

by Donnenfeld ED, Solomon KD, Voskanyan L, Chang DF, Samuelson TW, Ahmed II, Katz LJ
Published 2015-11-01

Long-term titrated IOP control with one, two, or three trabecular micro-bypass stents in open-angle glaucoma subjects on topical hypotensive medication: 42-month outcomes

by Katz LJ, Erb C, Carceller Guillamet A, Fea AM, Voskanyan L, Giamporcaro JE, Hornbeak DM
Published 2018-01-01

Prospective, randomized study of one, two, or three trabecular bypass stents in open-angle glaucoma subjects on topical hypotensive medication

by Katz LJ, Erb C, Carceller Guillamet A, Fea AM, Voskanyan L, Wells JM, Giamporcaro JE
Published 2015-12-01

A randomized, controlled trial to test the effectiveness of a glaucoma patient navigator to improve appointment adherence

by Hark LA, Johnson DM, Berardi G, Patel NS, Zeng L, Dai Y, Mayro EL, Waisbourd M, Katz LJ
Published 2016-09-01

Efficacy of two trabecular micro-bypass stents combined with topical travoprost in open-angle glaucoma not controlled on two preoperative medications: 3-year follow-up

by Chang DF, Donnenfeld ED, Katz LJ, Voskanyan L, Ahmed IIK, Samuelson TW, Giamporcaro JE, Hornbeak DM, Solomon KD
Published 2017-03-01

Prospective unmasked randomized evaluation of the iStent inject® versus two ocular hypotensive agents in patients with primary open-angle glaucoma

by Fea AM, Belda JI, Rękas M, Jünemann A, Chang L, Pablo L, Voskanyan L, Katz LJ
Published 2014-05-01